Modern DHA Field Force Alignment

Bottom Line:

The Defense Health Agency’s unified network model requires manufacturers to align sales force structures to properly leverage local clinical utilization into regional data for network-wide product adoption across the military health infrastructure

As the Defense Health Agency (DHA) combined its 20+ regional markets into 9 Defense Health Networks, it effectively rendered traditional commercial sales maps obsolete for this arena. Pharmaceutical and medical device manufacturers that continue to anchor their footprint in the DHA based on legacy models (i.e., zip-code-based territories, individual accounts, etc.) are operating with a fragmented and decoupled delivery system. This misalignment creates territory obsolescence by confining sales field representatives to commercial boundaries, resulting in unnecessary friction since localized efforts are separated from the DHA’s multi-facility, regional decision-making centers. Ultimately, this traditional approach neutralizes a product’s potential to demonstrate regional scale and operational efficiency.

Implementing a standard commercial model lacks the specialized framework required to translate frontline clinical utilization into macro-level network evidence, leaving innovations stranded at the individual facility level. The DHA’s centralized authority model supports mission-readiness and cost-efficiency through regional oversight; however, the strategic vulnerability for manufacturers lies in treating a single MTF visit as an ultimate milestone rather than a stepping stone towards the standardized regional clinical protocols designed to eliminate variance and enforce readiness.

The operational mechanics of the current enterprise are a distinct three-tier architecture:

While regional commands dictate top-down protocols, they do not establish these clinical boundaries in an administrative vacuum. Individual Military Treatment Facilities (MTFs) remain the vital testing grounds for proving real-world clinical optimization and product efficiencies. Regional network leaders routinely evaluate performance data directly from these field installations to determine which clinical practices deserve wider consideration and implementation. This means that local data is the primary fuel for the entire regional decision-making engine. When frontline point-of-care successes are effectively packaged into network-level evidence, regional commands can better incorporate those efficiencies into a standardization across all installations.

Remediating this disconnect does not require a reinvention of the broader commercial sales strategy. Instead, it demands a deliberate adjustment and increased internal communication. Field assets must be deployed with a clear understanding of how separate MTFs interact within the same network hierarchy. Consequently, a comprehensive evaluation of the current commercial sales footprint against the DHA’s regional command architecture is the necessary first step toward capturing the internal collaboration required to leverage individual MTF penetration into regional operational scalability. By identifying where current field boundaries cross distinct military networks, organizations can align their teams with the unified DHA command structure. It is therefore critical to move beyond account-by-account interactions to capture the overarching network utilization and procurement patterns that dictate system-wide product adoption.